in the new paper, “Organoids“, published in Nature Reviews, Dr. Wang and other leaders in organoid research highlight the rationale underlying the establishment of organoid cultures and provide guiding principles for selecting suitable materials, methods, and protocols for different applications. The critical considerations for generating robust organoids have been further discussed, such as those related to cell isolation and seeding, matrix and soluble factor selection, physical cues and integration (see Graphic Abstract below), as well as the general standards for data quality, reproducibility and deposition within the organoid community. It is a good resource for Methods and Protocols if you want to make organoids by yourself.

Dr. Wang has been awarded the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Trailblazer Award. This generous support from NIBIB will help Wang Lab to explore new oral drugs to treat inflammatory and infectious diseases using organoid platforms.

Dr. Wang participated in the American Society for Engineering Education (ASEE) 2022 Annual Conference. As the sponsor of ASEE, ISU had various sessions and programs. A lot of fun!

With Tissue Engineering SIG officers @NganHuang @GuldenCU at 2022 SFB Exhibit @SFBiomaterials

We’re less than one week away from the 2022 SFB Annual Meeting! Join us at the “Biomaterials for Organoids” Session and “Biomaterials for Regenerative Engineering” Session in Baltimore. A lot of great programs and SIG Mixer social. See you then!

New students, Jack Girton and Elijah Vanderkamp will join Wang Lab as Honor Research program researchers to work on organoids reprogramming and cell-mediated drug deliver projects. Chemical Engineering senior Zhao Ren Tan will start his research this Spring on the oral vaccine project. Welcome!

Dr. Wang has been nominated as a member of the Finance Committee for the Controlled Release Society (CRS). The overarching function of this standing committee is to provide advice to the Board on all financial matters, ensuring that the CRS will fulfill its Mission and move towards its aspirational Vision. Dr. Wang has had a long-term relationship with CRS since the 2010 Jorge Heller Postdoctoral Fellow supported by CRS. It’s a great honor to serve CRS, the leading society in the Drug Delivery field.

Tomorrow, Dr. Wang will talk at the 2021 AIChE Annual Meeting in Biotherapeutic Development and Delivery Session. The title is “Gut Organoid As a Platform for Evaluating the Delivery of Nanoparticles to Treat Gastrointestinal Diseases.” Join us to learn about organoids’ latest biotherapeutic technologies at 8:00 AM ET, Thursday, November 18, 2021. The Zoom Access Link: https://meetbreakout.zoom.us/j/92982577004?pwd=Vmt4c1ZKeitZaUZwMHpycUFUTHBxUT09

Dr. Wang will give a talk at Nanovaccines Institute on 4:00 PM Thurs., Oct. 28^th, about “Organoid as a New Platform to Develop Oral Vaccines and Nanomedicines.”

Please Join us Thurs., Oct. 28th for our @nanovax Seminar Series!

This live, virtual seminar will feature Dr. Qun Wang with @iastate @ISU_CBE

Register: https://conta.cc/3lrAWTA Learn more: https://bit.ly/3AwtKK3